Maissa El Said El Raziky

Cited by

	All	Since 2019
Citations	1810	847
h-index	26	15
i10-index	45	22

220

110

165

200520062007200820092010201120122013201420152016201720182019202020212022202320247 4 6 16 17 30 37 43 77 112 129 118 125 201 141 163 170 153 167 53

Public access

View all

2 articles

0 articles

available

not available

Based on funding mandates

Co-authors

I WakedProfessor of Medicine, National Liver Institute, EgyptVerified email at liver-eg.org
Abdel-Hamid MProfessorMedical Microbaiology and Immunology, Faculty of Medicine, Minia University, EgyptVerified email at minia.edu.eg
Magdy El-SerafyEndemic Medicine and Hepatogastroenterology, Cairo UniversityVerified email at kasralainy.edu.eg
Mohamed El-KassasEndemic Medicine Department, Faculty of Medicine, Helwan UniversityVerified email at hq.helwan.edu.eg
Olfat ShakerMedical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo UniversityVerified email at kasralainy.edu.eg
Naglaa ZayedProfessor of Hepatology and GastroenterologyVerified email at kasralainy.edu.eg
Rabab SalamaprofessorVerified email at cu.edu.eg
Mostafa Kamaleldin MohamedProfessor, Faculty of Medicine, Ain Shams UniversityVerified email at med.asu.edu.eg
Tamer ElbazAssistant Professor Endemic Hepatology and Gastroenterology, Cairo University, EgyptVerified email at kasralainy.edu.eg
Waleed FathalahAssistant professor of endemic medicine and hepatology, Cairo UniversityVerified email at kasralainy.edu.eg
Marwa KhairyProfessor of Endemic Medicine Department and Hepatology Unit, Faculty of Medicine, CairoVerified email at cu.edu.eg
Abdel Aziz ShaheenUniversity of CalgaryVerified email at ucalgary.ca
Mohamed AbdAllahNational Research CenterVerified email at nrc.sci.eg
Mohamed MetwallyProfessor of Hepatology and GastroenterologyVerified email at fmed.bu.edu.eg
Nabiel MikhailDept of Biostatistics and Cancer Epidemiology, SECI, Assiut UniversityVerified email at aun.edu.eg
OLA HASSAN NADAProfessor of Pathology, Faculty of Medicine, Ain Shams UniversityVerified email at med.asu.edu.eg
Samar DarweeshHepatogastroenterology and Endemic Medicine Department, Faculty of Medicine, Cairo UniversityVerified email at cu.edu.eg
Heba OmarAssociate Professor at Endemic Medicine and Hepatology Department, Faculty of Medicine, CairoVerified email at kasralainy.edu.eg
Mona S El-RazikyProfessor of Pediatrics, Cairo UniversityVerified email at kasralainy.edu.eg
Gamal E. ShihaProfessor of Internal Medicine, Mansoura UniversityVerified email at mans.edu.eg

Maissa El Said El Raziky

Professor of Endemic Medicine, Faculty of Medicine, Cairo University

Verified email at kasralainy.edu.eg

Infectious diseases Hepatology Gastroenterology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022	166	2022
Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon A Elsharkawy, SA Alem, R Fouad, M El Raziky, W El Akel, M Abdo, ... Journal of gastroenterology and hepatology 32 (9), 1624-1630, 2017	98	2017
Sofosbuvir‐based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt A Elsharkawy, R Fouad, W El Akel, M El Raziky, M Hassany, G Shiha, ... Alimentary pharmacology & therapeutics 45 (5), 681-687, 2017	80	2017
Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C G Esmat, M Metwally, KR Zalata, S Gadalla, M Abdel-Hamid, A Abouzied, ... Journal of hepatology 46 (4), 620-627, 2007	78	2007
Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: lessons from the Egyptian experience A Elsharkawy, M El-Raziky, W El-Akel, K El-Saeed, R Eletreby, ... Journal of hepatology 68 (4), 691-698, 2018	73	2018
Response to pegylated interferon alfa‐2a and ribavirin in chronic hepatitis C genotype 4 HE Makhzangy, G Esmat, M Said, M ElRaziky, S Shouman, R Refai, ... Journal of medical virology 81 (9), 1576-1583, 2009	73	2009
Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients R Eletreby, W Elakel, M Said, M El Kassas, S Seif, T Elbaz, M El Raziky, ... Liver International 37 (4), 534-541, 2017	67	2017
Predictors of a sustained virological response in patients with genotype 4 chronic hepatitis C RR Gad, S Males, H El Makhzangy, S Shouman, A Hasan, M Attala, ... Liver International 28 (8), 1112-1119, 2008	60	2008
The effect of peginterferon alpha-2a vs. peginterferon alpha-2b in treatment of naive chronic HCV genotype-4 patients: a single centre Egyptian study M El Raziky, WF Fathalah, WA El-Akel, A Salama, G Esmat, M Mabrouk, ... Hepatitis Monthly 13 (5), 2013	58	2013
Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response M Abdel-Rahman, M El-Sayed, M El Raziky, A Elsharkawy, W El-Akel, ... World Journal of Gastroenterology: WJG 19 (17), 2691, 2013	52	2013
Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy MK El Awady, MA Anany, G Esmat, N Zayed, AA Tabll, A Helmy, ... Journal of gastroenterology and hepatology 26 (5), 843-850, 2011	50	2011
APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: Systematic review and meta-analysis MA El Serafy, AM Kassem, H Omar, MS Mahfouz, EL Maissa El Said Arab Journal of Gastroenterology 18 (2), 51-57, 2017	49	2017
Non-invasive prediction of hepatic fibrosis in patients with chronic HCV based on the routine pre-treatment workup M Khairy, M Abdel-Rahman, M El-Raziky, W El-Akel, N Zayed, H Khatab, ... Hepatitis monthly 12 (11), 2012	45	2012
Hepatitis C virus infection in Egyptian children: single centre experience MS El‐Raziky, M El‐Hawary, N El‐Koofy, S Okasha, M Kotb, K Salama, ... Journal of viral hepatitis 11 (5), 471-476, 2004	45	2004
Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis M El Raziky, M Gamil, MK Ashour, EA Sameea, W Doss, Y Hamada, ... Journal of viral hepatitis 24 (2), 102-110, 2017	36	2017
The future for the treatment of genotype 4 chronic hepatitis C G Esmat, M El Raziky, M El Kassas, M Hassany, ME Gamil Liver International 32, 146-150, 2012	36	2012
Optimizing treatment for HCV genotype 4: PEG‐IFN alfa 2a vs. PEG‐IFN alfa 2b; the debate continues G Esmat, M El Kassas, M Hassany, M Gamil, M El Raziky Liver International 34, 24-28, 2014	35	2014
Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4 G Esmat, T Elbaz, M El Raziky, A Gomaa, M Abouelkhair, HG El Deen, ... Journal of hepatology 68 (1), 53-62, 2018	31	2018
Assessment of hepatic fibrosis in pediatric cases with hepatitis C virus in Egypt MA El-Hawary, MS El-Raziky, G Esmat, H Soliman, A Abouzied, ... World Journal of Gastroenterology: WJG 13 (20), 2846, 2007	31	2007
NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon–ribavirin therapy in Egyptian patients A El-Shamy, I Shoji, W El-Akel, SE Bilasy, L Deng, M El-Raziky, D Jiang, ... Journal of clinical microbiology 50 (12), 3886-3892, 2012	29	2012

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors